(Q36098773)

12 August 2017

1 reference

title

Accumulation of metals and minerals from phosphate binders (English)

1 reference

12 August 2017

Donald A Molony

1

1 reference

12 August 2017

Bhamidipati Murthy

series ordinal

2

1 reference

12 August 2017

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

23 Suppl 1

1 reference

12 August 2017

page(s)

2-11

1 reference

Phosphate binders in uraemia: pharmacodynamics, pharmacoeconomics, pharmacoethics

12 August 2017

cites work

1 reference

Hyperaluminaemia from aluminum resins in renal failure.

21 January 2018

1 reference

Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium

21 January 2018

1 reference

Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey

21 January 2018

1 reference

The potential role of aluminium in Alzheimer's disease

21 January 2018

1 reference

Aluminium: Gastrointestinal absorption and renal excretion

21 January 2018

1 reference

Intestinal absorption of aluminium in renal failure.

21 January 2018

1 reference

Suboptimal dietary zinc intake increases aluminum accumulation into the rat brain.

21 January 2018

1 reference

Oral aluminum administration to rats with normal renal function. 2. Body distribution

21 January 2018

1 reference

Reconsidering the importance of long-term low-level aluminum exposure in renal failure patients

21 January 2018

1 reference

Bone disease and aluminum: pathogenic considerations

21 January 2018

1 reference

Cadmium overload and toxicity

21 January 2018

1 reference

The role of trace elements in uraemic toxicity

21 January 2018

1 reference

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

21 January 2018

1 reference

The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis

21 January 2018

1 reference

The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients

21 January 2018

1 reference

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

21 January 2018

1 reference

Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study).

21 January 2018

1 reference

Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia

21 January 2018

1 reference

Management of hyperphosphataemia of chronic kidney disease: lessons from the past and future directions

21 January 2018

1 reference

A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients

21 January 2018

1 reference

First International Summit on Kidney Disease Prevention, 25-27 July 2002: consensus document

21 January 2018

1 reference

A comparison of clinically useful phosphorus binders for patients with chronic kidney failure

21 January 2018

1 reference

The acute mammalian toxicity of rare earth nitrates and oxides

21 January 2018

1 reference

Improving outcomes in hyperphosphataemia

21 January 2018

1 reference

Neurotoxicity of lanthanum chloride in newborn chicks

21 January 2018

1 reference

Neurodevelopmental effects of lanthanum in mice.

21 January 2018

1 reference

Induction of autoimmunity through bystander effects. Lessons from immunological disorders induced by heavy metals

21 January 2018

1 reference

Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia

21 January 2018

1 reference

Musculoskeletal manifestations of chronic renal failure

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000083712

1 reference

12 August 2017

1 reference